Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
420 questions in 57 reviews · Gut
current versionsNo studies 420 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Biofeedback vs relaxation training Serious adverse events (SAE) · people with irritable bowel syndrome Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Biofeedback plus standard therapy vs sham biofeedback plus standard therapy Quality of life (QoL) · people with irritable bowel syndrome Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Biofeedback plus standard therapy vs sham biofeedback plus standard therapy Adverse events (AE) · people with irritable bowel syndrome Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Biofeedback plus standard therapy vs sham biofeedback plus standard therapy Serious adverse events (SAE) · people with irritable bowel syndrome Biofeedback for treatment of irritable bowel syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants vs placebo Pain · participants with active and inactive inflammatory bowel disease Adjuvant therapy with antidepressants for the management of inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Infertility at 24 months · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Miscarriage · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Stillbirth · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Use of ART · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Caesarean section · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Preterm delivery · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Low birth weight · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic vs open surgery Small for gestational age · females with inflammatory bowel disease The impact of surgical therapies for inflammatory bowel disease on female fertility (2019) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic with anti‐TNF vs placebo with anti‐TNF Failure to maintain endoscopic remission · Participants with active CD Antibiotics for induction and maintenance of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic with anti‐TNF vs placebo with anti‐TNF Serious adverse events · Participants with active CD Antibiotics for induction and maintenance of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic vs placebo Failure to maintain endoscopic remission · Participants with active CD Antibiotics for induction and maintenance of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic with anti‐TNF vs placebo with anti‐TNF Failure to enter clinical remission · Participants with active CD Antibiotics for induction and maintenance of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic with anti‐TNF vs placebo with anti‐TNF Failure to maintain clinical remission · Participants with active CD Antibiotics for induction and maintenance of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Health‐related quality of life · people with inactive Crohn's disease Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Adverse events · people with inactive Crohn's disease Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Health‐related quality of life · people with active ulcerative colitis Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Adverse events · people with active ulcerative colitis Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Adverse events · Participants with inactive ulcerative colitis Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention diet vs control diet Adverse events · people with active Crohn's disease Dietary interventions for induction and maintenance of remission in inflammatory bowel disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR OutcomesAnalysis 1.4 · Patients with active Crohn's disease Adalimumab for induction of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Endoscopic response · Patients with active Crohn's disease Adalimumab for induction of remission in Crohn's disease (2019) · Cochrane | no estimate extracted | NR | No studies |
High‐volume continuous veno‐venous hemofiltration (CVVH) vs standard CVVH Length of hospital stay · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
High‐volume continuous veno‐venous hemofiltration (CVVH) vs standard CVVH Total hospital cost · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
High‐volume continuous veno‐venous hemofiltration (CVVH) vs standard CVVH Quality of life · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Continuous veno‐venous hemofiltration (CVVH) vs no CVVH Adverse events · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Continuous veno‐venous hemofiltration (CVVH) vs no CVVH Quality of life · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
High‐volume continuous veno‐venous hemofiltration (CVVH) vs standard CVVH Length of ICU stay · adults with severe acute pancreatitis Continuous veno‐venous hemofiltration for severe acute pancreatitis (2019) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs no supplementation Change in height · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs no supplementation Change in quality of life · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs 6‐MP Change in weight · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs 6‐MP Change in height · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs 6‐MP Change in quality of life · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs polymeric formula supplements Change in weight · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs 6‐MP Withdrawal due to adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs mesalamine Change in height · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs mesalamine Change in quality of life · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs mesalamine Adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs mesalamine Serious adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Enteral nutrition vs mesalamine Withdrawal due to adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs polymeric formula supplements Change in height · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs polymeric formula supplements Change in quality of life · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs polymeric formula supplements Adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs polymeric formula supplements Serious adverse events · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Elemental formula supplements vs no supplementation Change in weight (kg) · Participants with Crohn's disease in remission Enteral nutrition for maintenance of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |
Three infusions of natalizumab (300 mg) and two infusions of infliximab (5 mg/kg) vs placebo and two infusions of infliximab Failure to induce clinical response at 10 weeks · Participants with active Crohn's disease despite current treatment with infliximab Natalizumab for induction of remission in Crohn's disease (2018) · Cochrane | no estimate extracted | NR | No studies |